Key points of Antibody Drug Conjugates (ADCs) development

The target/antigen is the starting point in developing ADCs and determines which tumor indication will be targeted by ADCs and potentially impacts the choice of the conjugated drug payload. Choosing the right target is critical for ADCs development. In this application note, ACROBiosystems outline the key points for developing ADCs.